Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales20 24720 40520 85326 47027 83529 378
EBITDA3 8654 8504 9757 0407 4338 168
Operating profit (EBIT)2 8723 9794 1725 7626 2396 666
Pre-Tax Profit (EBT)------
Net income2 2844 4231 4002 3483 6744 165
P/E ratio30,215,440,944,927,421,7
EPS ( $ )1,492,920,941,091,782,25
Dividend per Share ( $ )0,900,981,041,071,121,19
Yield2,00%2,18%2,71%2,19%2,29%2,43%
Reference price ( $ )45.0244.9138.4148.8848.8848.88
Announcement Date01/29/2015
12:45pm
01/28/2016
12:31pm
01/25/2017
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt3 7822 8763 23114 98212 5199 577
Finance------
Operating income (EBITDA)3 8654 8504 9757 0407 4338 168
Leverage
(Debt/EBITDA)
0,98x0,59x0,65x2,13x1,68x1,17x
Capital Expenditure1 0771 1101 1211 2011 2621 232
Book Value Per Share (BVPS)14,3 $14,4 $13,9 $18,5 $19,2 $20,3 $
Cash Flow per Share2,41 $1,97 $2,16 $2,82 $3,89 $4,18 $
Announcement Date01/29/2015
12:45pm
01/28/2016
12:31pm
01/25/2017
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 84 926 M$ -
Entreprise Value (EV) 99 908 M$ 97 445 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 44,9x 27,4x
Capitalization / Revenue 3,21x 3,05x
EV / Revenue 3,77x 3,50x
EV / EBITDA 14,2x 13,1x
Yield (DPS / Price) 2,19% 2,29%
Price to book (Price / BVPS) 2,65x 2,54x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 21,8% 22,4%
operating Leverage (Delta EBIT / Delta Sales) 1,41x 1,61x
Net Margin (Net Profit / Revenue) 8,87% 13,2%
ROA (Net Profit / Asset) 6,53% 6,87%
ROE (Net Profit / Equities) 16,4% 15,6%
Rate of Dividend 98,5% 62,8%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   4,54% 4,53%
Cash Flow / Sales 18,5% 24,3%
Capital Intensity (Assets / Sales) 1,36x 1,92x
Financial Leverage (Net Debt / EBITDA) 2,13x 1,68x
EPS & Dividend